Antibody imaging in the evaluation of cardiovascular diseases

Journal of Nuclear Cardiology

Volumn 1, Issue 5, 1994, Pages 457-476

  Khaw, Ban An ^a   Narula, Jagat ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

acute myocardial infarction; antimyosin antibody; atherosclerosis; deep vein thrombosis; heart transplant rejection; immunoscintigraphy; myocarditis; negative charge modification of antibody; pulmonary emboli

Indexed keywords

ANTIBODY; MYOSIN ANTIBODY; TECHNETIUM 99M;

ACUTE HEART INFARCTION; ATHEROSCLEROSIS; DEEP VEIN THROMBOSIS; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LUNG EMBOLISM; REVIEW; SCANNING ELECTRON MICROSCOPY;

ANIMAL; ARTERIOSCLEROSIS; CARDIOVASCULAR DISEASES; FIBRIN; GRAFT REJECTION; HEART TRANSPLANTATION; HUMAN; MYOCARDIAL INFARCTION; MYOCARDITIS; MYOSINS; RADIOIMMUNODETECTION;

EID: 0028081640     PISSN: 10713581     EISSN: 15326551     Source Type: Journal    
DOI: 10.1007/BF02961600     Document Type: Review

References (98)

1. Protein purification by affinity chromatography: derivation of agarose and polyamine beads
2. Continuous cultures of fused cells secreting antibody of predefined specificity
3. Localization of cardiac myosin-specific antibody in myocardial infarction
4. Myocardial injury: quantitation by cell sorting initiated with anti-myosin fluorescent spheres
5. 131I-labeled anticardiac myosin (Fab′)2 fragments
6. The hydrolysis of rabbit γ-globulin and antibodies with crystalline papain
7. Improved tumor localization with strept (avid) and labeled biotin as a substitute for antibody
8. Sequential imaging of indium-111 labeled monoclonal antibody in human mammary tumors hosted in nude mice
9. Magic bullets: from muskets to smart bombs
10. When magic bullets ricochet
11. Monoclonal antibody to cardiac myosin: scintigraphic imaging of experimental myocardial infarction
12. The relationship of immediate and delayed thallium-201 distribution to localization of I-125-antimyosin antibody in acute experimental myocardial infarction
13. Comparative assessment of experimental myocardial infarction with Tc-99m hexakis-t-butyl-isonitrile (sestamibi), In-111 antimyosin and Tl-201
14. Specificity of localization of myosin specific antibody fragments in experimental myocardial infarction: histologic, histochemical, autoradiographic and scintigraphic studies
15. Myocardial damage delineated by In-111 antimyosin Fab and Tc-99m-pyrophosphate
16. Hyperacute visualization of myocardial infarction with Tc-99m glucarate: comparison with Tl-210, in-111-antimyosin
17. Scintigraphic quantification of myocardial necrosis in patients after intravenous injection of myosin-specific antibody
18. Acute myocardial infarct imaging with indium-111 labeled monoclonal antimyosin Fab fragments
19. Value of indium-111 monoclonal antimyosin antibody for imaging in acute myocardial infarction
20. Diagnosis of acute myocardial infarction by indium-111 antimyosin antibody and correlation with traditional techniques for the evaluation of extent and localization
21. Measurement of acute Q-wave myocardial infarct size with SPECT imaging of indium-111-antimyosin
22. Antimyosin imaging in acute transmural myocardial infarction: results of a multicenter clinical trial
23. Antimyosin imaging in patients with ischemic chest pain: initial results of phase III multicenter trial [Abstract]
24. Immunoscintigraphy for detecting acute myocardial infarction without electrocardiographic changes
25. Diagnosis of right ventricular infarction by dual isotope thallium-201, and indium-111-monoclonal antimyosin SPECT imaging
26. Frequency of myocardial indium-111 antimyosin uptake after uncomplicated coronary artery bypass surgery
27. Indium-111 antimyosin antibody imaging for detecting different stages of myocardial infarction: comparison with technetium-99m-pyrophosphate imaging
28. 111-Indium antimyosin antibody uptake is related to the age of myocardial infarction
29. Time course of myocardial infarction evaluated by indium-111-antimyosin monoclonal antibody scintigraphy: clinical implications and prognostic value
30. Early detection of rejection and assessment of cyclosporine therapy by indium-111 antimyosin imaging in mouse heart allografts
31. Imaging of cardiac allograft rejection in dogs using indium-111 monoclonal antimyosin Fab
32. Noninvasive detection of human cardiac transplant rejection with In-111 antimyosin (Fab) imaging
33. Patterns of evolution of myocyte damage after human heart transplantation detected by indium-111 monoclonal antimyosin
34. Early postoperative reduction of monoclonal antimyosin antibody uptake is associated with absent rejection-related complications after heart transplantation
35. 111In-monoclonal antimyosin antibody studies after the first year of heart transplantation: identification of risk groups for developing rejection during long-term follow-up and clinical implications
36. Myocarditis: a histopathologic definition and classification
37. Indium 111-monoclonal antimyosin antibody imaging in the diagnosis of acute myocarditis
38. Indium-111 antimyosin scintigraphy to assess myocardial damage in patients with suspected myocarditis and cardiac rejection
39. Antimyosin scintigraphy in detection of myocarditis: evaluation of a diagnostic methodology [Abstract]
40. Antimyosin antibody cardiac imaging: its role in the diagnosis of myocarditis
41. Active myocarditis in spectrum of acute dilated cardiomyopathies: clinical features, histological correlates and clinical outcome
42. Idiopathic ventricular tachycardia
43. Recognition of acute myocarditis masquerading as acute myocardial infarction
44. Evaluation of postmortem endomyocardial biopsy specimens from 38 patients with lymphocytic myocarditis: implications for role of sampling error
45. High prevalence of ongoing myocyte damage in patients with chronic dilated cardiomyopathy
46. Cardiomyopathy and specific heart muscle disease
47. Lyme myocarditis diagnosed by indium-111 antimyosin antibody scintigraphy
48. Scintigraphy using 111-indium-labeled antimyosin in ChurgStrauss vasculitis with myocardial involvement
49. 111-Indium antimyosin antibody imaging for diagnosis of rheumatic carditis
50. Case records of the Massachusetts General Hospital
51. Detection of preformed venous thrombi in dogs by means of I131-labeled antibodies to dog fibrinogen
52. Isotopic detection of thrombi
53. Radiolabeled antihuman fibrin antibody: a new thrombus-detecting agent
54. Discrimination between fibrin and fibrinogen by a monoclonal antibody against a synthetic peptide
55. Monoclonal antibodies to a synthetic fibrin-like peptide bind to human fibrin but not fibrinogen
56. Structural basis for species selectivity of a fibrin specific monoclonal antibody
57. Specificity of a monoclonal antibody for the NH2-terminal region of fibrin
58. 99mTc-antifibrin Fab′ fragments for imaging venous thrombi: evaluation in a canine model
59. A fibrin specific monoclonal antibody which interferes with the fibrinolytic effect of tissue plasminogen activator
60. An antifibrin monoclonal antibody useful in immunoscintigraphic detection of thrombi
61. Binding properties of monoclonal antibodies against human fragment D-dimer of cross-linked fibrin to human plasma clots in an in vivo model in rabbits
62. Thrombosis imaging: a comparison of radiolabeled GC4 and T2G1s fibrin-specific monoclonal antibodies
63. Measurement of crosslinked fibrin degradation products: an immunoassay using monoclonal antibodies
64. An immunoassay for human d dimer using monoclonal antibodies
65. Imaging thrombi in a rabbit jugular vein with technetium-99m MH-1 monoclonal antibody [Abstract]
66. Imaging of human thrombi in the rabbit jugular vein, I: comparison of two fibrin-specific monoclonal antibodies
67. 111In
68. Deep vein thrombosis: scintigraphic diagnosis with In-111-labeled monoclonal antifibrin antibodies
69. 111In-labeled antifibrin monoclonal antibody for the diagnosis of venous thrombotic disease
70. Accurate diagnosis of acute deep venous thrombosis with technetium-99m antifibrin scintigraphy: final phase III results [Abstract]
71. Detection of deep vein thrombi and pulmonary embolus with technetium-99m-DD-3B6/22 anti-fibrin monoclonal antibody Fab′ fragment
72. Localization and visualization of pulmonary emboli with radiolabeled fibrin-specific monoclonal antibody
73. Differential sensitivity of erythrocyte-rich and platelet-rich arterial thrombi to lysis with recombinant tissue-type plasminogen activator: a possible explanation of resistance to coronary thrombolysis
74. Thrombus radioimmunoscintigraphy: an approach using monoclonal antiplatelet antibody
75. Differences in in vivo behavior of In-111 and 1–125 labeled antiplatelet antibody (7E3) in dogs with experimental pulmonary emboli
76. 99mTc S12 antibody imaging of platelet alpha granules in rabbit endothelial neointimal proliferation after angioplasty
77. Imaging of vascular injury with Tc-99m-labeled monoclonal antiplatelet antibody S12: preliminary experience in human percutaneous transluminal angioplasty
78. 99mTc-labeled LDL
79. 111In oxime for reinjection in patients with atherosclerosis
80. 111In-labeled platelet scintigraphy in carotid atherosclerosis
81. Noninvasive localization of experimental atherosclerotic lesions with murine/human chimeric antibody Z2D3 F(ab′)2
82. 2
83. Increased expression of HLA-DR antigens on renal tubular cells in renal transplants: relevance to the rejection response
84. Aberrant expression of HLA-DR antigen on thyrocytes in Graves’ disease: relevance for autoimmunity
85. HLA restriction of cell mediated lysis of influenza virus-infected human cells
86. Induction of major histocompatibility complex antigens within the myocardium of patients with active myocarditis: a nonhistologic marker of myocarditis
87. Imaging the rejecting heart: in vivo detection of major histocompatability complex class II antigen induction
88. Imaging of ICAM-1 induction in rejecting hearts: a new scintigraphic approach to detect early allograft rejection [Abstract]
89. Rapid infarct imaging with a technetium-99m-labeled antimyosin recombinant single-chain Fv: evaluation in a canine model of acute myocardial infarction
90. Single chain antigen binding proteins
91. Protein engineering of antibody binding sites: recovery of specific activity in an antidigoxin single chain Fv analogue produced in E. coli.
92. Thrombus imaging with Tc-99m synthetic peptides reactive with activated platelets
93. Design and synthesis of a mimetic from an antibody complementary determining region
94. Theory of the electrokinetic behavior of human erythrocytes
95. Presence of heparan sulfate in the glomerular basement membrane
96. Induction of rabbit antibody with molecular uniformity after immunization with group C streptococci
97. Gamma imaging with negatively charge-modified monoclonal antibody: modification with synthetic polymers